A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy

Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma

NCT00671268 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis

NCT01484119 ·Status: COMPLETED ·Phase: PHASE3

Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients

NCT03369704 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With Asthma

NCT03394508 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma

NCT00135642 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies

NCT00720278 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine

NCT03755713 ·Status: COMPLETED ·Phase: PHASE1

Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma

NCT02161107 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma

NCT02061670 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis

NCT00720382 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy

NCT02423707 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen

NCT04891237 ·Status: RECRUITING ·Phase: PHASE3

Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis

NCT04088721 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis

NCT00407927 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation

NCT00623701 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies

NCT00712920 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies

NCT00719862 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis

NCT07291284 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study In Adults And Adolescents With Seasonal Allergic Rhinitis.

NCT00225823 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites

NCT01013116 ·Status: UNKNOWN ·Phase: PHASE3

Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action

NCT00118729 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

NCT00660829 ·Status: COMPLETED ·Phase: PHASE3

Effect of the GSK2245035 on the Allergen-induced Asthmatic Response

NCT02833974 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis

NCT01018862 ·Status: COMPLETED ·Phase: PHASE3

Phase I Study of PollenVax in Patients With Mugwort Pollen-Induced Allergic Rhinitis

NCT07317960 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1